Published in Brain Res on April 16, 1993
Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev (1998) 7.89
Mycoplasma membrane lipoproteins induced proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect Immun (1996) 1.34
Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation (2008) 1.32
Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics (2010) 1.17
Mycoplasma hyorhinis molecules that induce tumor necrosis factor alpha secretion by human monocytes. Infect Immun (1995) 0.93
Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion. Br J Pharmacol (2001) 0.79
Pathogenicity of Mycoplasma fermentans and Mycoplasma penetrans in experimentally infected chicken embryos. Infect Immun (1996) 0.79
Production, regulation and role of nitric oxide in glial cells. Mediators Inflamm (1998) 0.77
Mycoplasma fermentans-induced inflammatory response of astrocytes: selective modulation by aminoguanidine, thalidomide, pentoxifylline and IL-10. Inflammation (1999) 0.75
The role of macrophages in the induction of antibody in x-irradiated animals. Immunology (1967) 5.36
Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med (1997) 2.21
Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med (1991) 2.05
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A (2000) 1.96
Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet (1975) 1.66
Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis. Clin Exp Immunol (1975) 1.59
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J Clin Invest (1988) 1.57
Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma. Neurology (1998) 1.50
Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J Neuroimmunol (1997) 1.49
Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J Cereb Blood Flow Metab (1994) 1.49
Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide. Ann Neurol (1993) 1.48
Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. Ann Neurol (1998) 1.46
High frequency of hemorrhagic strokes in Jerusalem during the Persian Gulf War. Neurology (1992) 1.43
Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor. Nature (1975) 1.43
An association between multiple sclerosis and type I diabetes mellitus. J Neurol (1992) 1.42
Lack of hemispheric localizing value of the palmomental reflex. Neurology (2005) 1.40
Specificity and nature of binding of antimacrophage serum. Immunology (1972) 1.38
Serum Cu/Zn superoxide dismutase activity is reduced in sporadic amyotrophic lateral sclerosis patients. J Neurol Sci (1996) 1.38
Primary stimulation of rats and mice with hemocyanin in soluton and adsorbed on bentonite. J Immunol (1968) 1.36
Enhanced chemotactic and phagocytic activities of leukocytes in psoriasis vulgaris. J Invest Dermatol (1978) 1.26
Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury. J Cereb Blood Flow Metab (1996) 1.23
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity (2006) 1.22
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol (1997) 1.22
Acute and chronic demyelinating inflammatory polyradiculoneuropathy. Association with autoimmune diseases and lymphocyte response to human neuritogenic protein. Arch Neurol (1986) 1.20
Mycoplasma capricolum membranes induce tumor necrosis factor alpha by a mechanism different from that of lipopolysaccharide. Cancer Immunol Immunother (1990) 1.20
Antibodies to oligodendroglia in patients with multiple sclerosis. N Engl J Med (1977) 1.20
Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J Immunol (1997) 1.19
Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol (1984) 1.16
Inosiplex in the treatment of subacute sclerosing panencephalitis. Arch Neurol (1979) 1.16
Guillain-Barré syndrome after epidural anesthesia: direct nerve root damage may trigger disease. Neurology (1985) 1.16
In vitro and in vivo studies of the properties and effects of antimacrophage sers (AMS). Clin Exp Immunol (1971) 1.15
Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide. JPEN J Parenter Enteral Nutr (1993) 1.14
Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis. J Infect Dis (1997) 1.13
Recurrence of acute disseminated encephalomyelitis at the previously affected brain site. Arch Neurol (2001) 1.13
Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease. Pediatrics (1985) 1.11
Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J Clin Invest (1991) 1.10
Passive transfer of experimental autoimmune myasthenia by lymph node cells in inbred guinea pigs. J Exp Med (1975) 1.10
Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients. Isr J Med Sci (1978) 1.09
Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur J Immunol (1994) 1.08
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study. Mult Scler (2010) 1.07
Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. J Control Release (2003) 1.06
Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch Neurol (1999) 1.06
The induction of antibody production in x-irradiated animals by macrophages that interacted with antigen. Isr J Med Sci (1967) 1.05
Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis. Proc Natl Acad Sci U S A (1975) 1.03
Effect of X-irradiation on various functions of murine macrophages. Clin Exp Immunol (1974) 1.03
HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch Neurol (1999) 1.02
Myasthenia gravis and acetylcholine receptor. Effect of steroids in clinical course and cellular immune response to acetylcholine receptor. Arch Neurol (1975) 1.01
Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever). Am J Med Sci (1981) 1.01
Association of MS with thyroid disorders. Neurology (1999) 1.01
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). Proc Natl Acad Sci U S A (1993) 1.00
Ontogeny of macrophage resistance to mouse hepatitis in vivo and in vitro. J Exp Med (1967) 1.00
Regulated expression of proenkephalin A in normal lymphocytes. J Immunol (1989) 0.99
Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone. J Neuroimmunol (2001) 0.99
Monocyte function in psoriasis. J Invest Dermatol (1979) 0.99
Complete unilateral ophthalmoplegia as the presenting manifestation of Waldenström's macroglobulinemia. Neurology (1990) 0.99
Macrophage phagocytic recognition sites. Demonstration of selectivity by hetero- and alloantisera. Immunology (1977) 0.99
Motion of spin-labeled fatty acids in murine macrophages. Relation to cellular phagocytic activity. Biochim Biophys Acta (1976) 0.98
Ictal hemiparesis. Eur Neurol (1982) 0.98
Sensory peripheral neuropathy of vitamin B12 deficiency: a primary demyelinating disease? J Neurol (1988) 0.98
Neurologic manifestations of progressive systemic sclerosis. Arch Neurol (1992) 0.98
Macrophage fatty acid composition and phagocytosis: effect of unsaturation on cellular phagocytic activity. Immunology (1979) 0.97
Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J Neurol Sci (1994) 0.97
Hereditary branching enzyme dysfunction in adult polyglucosan body disease: a possible metabolic cause in two patients. Ann Neurol (1991) 0.96
Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation. J Clin Invest (1993) 0.95
Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid. J Pharmacol Exp Ther (1997) 0.95
In vitro induction of tumor necrosis factor alpha, tumor cytolysis, and blast transformation by Spiroplasma membranes. J Natl Cancer Inst (1990) 0.95
A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol (1998) 0.95
The effect of macrophage hydrolytic enzyme levels on the uptake and degradation of antigen and immune complexes. J Reticuloendothel Soc (1975) 0.95
Neurological features as presenting manifestations of brucellosis. Eur Neurol (1977) 0.95
Treatment and prevention of acute hepatic encephalopathy by intravenous levodopa. Surgery (1974) 0.94
Cytokeratin expression in human thymus: immunohistochemical mapping. Cell Tissue Res (1995) 0.94
The capacity of macrophage components to inhibit anti-macrophage serum activity. Eur J Immunol (1973) 0.94
Electrophysiological examinations of the visual system in multiple sclerosis. J Neurol Sci (1973) 0.94
Allogeneic recognition and killing capacity of immune macrophages in mixed macrophage cultures (MMC). Cell Immunol (1975) 0.94
Cognitive dysfunction following thalamic stroke: a study of 16 cases and review of the literature. J Neurol Sci (2000) 0.93
Parkinsonism and hyperthyroidism. Eur Neurol (1974) 0.93
Ampicillin may aggravate clinical and experimental myasthenia gravis. Arch Neurol (1986) 0.93
Studies on the recognition of xenogeneic cells by nonimmune macrophages. I. Destruction of chicken fibroblasts in vitro by murine macrophages. Cell Immunol (1977) 0.92
The effect of irradiation on the release of lymphocyte-activating factor (LAF). Cell Immunol (1973) 0.92
Monocyte function in rheumatoid arthritis. Scand J Rheumatol (1980) 0.91
Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol (1992) 0.91
Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy. Mult Scler (2003) 0.90
Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation. Neurology (1996) 0.90
Studies on the binding and phagocytic inhibition properties of antimacrophage globulin (AMG). Immunology (1974) 0.90
Oral administration of the oxidant-scavenger N-acetyl-L-cysteine inhibits acute experimental autoimmune encephalomyelitis. J Neuroimmunol (1994) 0.90
Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers. Br J Clin Pharmacol (1980) 0.90
Antiacetylcholine receptor antibody in neonatal myasthenia gravis. Am J Dis Child (1981) 0.89
Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers. Eur J Clin Pharmacol (1984) 0.89
Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis. Proc Natl Acad Sci U S A (1996) 0.89
Cell-mediated immunity to neural antigens in idiopathic polyneuritis and myeloradiculitis. Clinical-immunologic classification of several autoimmune demyelinating disorders. Neurology (1975) 0.88
Induction of macrophage-mediated cytolysis of neoplastic cells by mycoplasmas. Cell Immunol (1983) 0.88
Treatment of acute hepatic encephalopathy with L-dopa. Postgrad Med J (1977) 0.88
Neurologic manifestations in patients with mixed cryoglobulinemia. Neurology (1974) 0.88
Trophoblasts protect the inner cell mass from macrophage destruction. Biol Reprod (1993) 0.87
Mast cell differentiation depends on T cells and granule synthesis on fibroblasts. Immunology (1983) 0.87